AdaptHealth Corp. (AHCO)
AHCO Stock Price Chart
Explore AdaptHealth Corp. interactive price chart. Choose custom timeframes to analyze AHCO price movements and trends.
AHCO Company Profile
Discover essential business fundamentals and corporate details for AdaptHealth Corp. (AHCO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
31 May 2018
Employees
10.50k
Website
https://adapthealth.comCEO
Suzanne Foster
Description
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
AHCO Financial Timeline
Browse a chronological timeline of AdaptHealth Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.15, while revenue estimate is $848.59m.
Earnings released on 5 May 2026
EPS came in at -$0.06 falling short of the estimated $0.01 by -580.00%, while revenue for the quarter reached $819.80m , beating expectations by +2.91%.
Earnings released on 24 Feb 2026
EPS came in at $0.27 falling short of the estimated $0.34 by -20.59%, while revenue for the quarter reached $846.29m , beating expectations by +1.77%.
Earnings released on 4 Nov 2025
EPS came in at $0.22 falling short of the estimated $0.24 by -8.33%, while revenue for the quarter reached $820.31m , missing expectations by -1.46%.
Earnings released on 5 Aug 2025
EPS came in at $0.01 falling short of the estimated $0.15 by -93.33%, while revenue for the quarter reached $800.37m , beating expectations by +0.15%.
Earnings released on 6 May 2025
EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $580.47m , missing expectations by -28.17%.
Earnings released on 25 Feb 2025
EPS came in at $0.39 surpassing the estimated $0.25 by +56.00%, while revenue for the quarter reached $856.65m , beating expectations by +6.78%.
Earnings released on 5 Nov 2024
EPS came in at $0.15 falling short of the estimated $0.17 by -11.76%, while revenue for the quarter reached $805.86m , missing expectations by -2.81%.
Earnings released on 6 Aug 2024
EPS came in at $0.21 surpassing the estimated $0.19 by +10.53%, while revenue for the quarter reached $805.98m , beating expectations by +0.42%.
Earnings released on 7 May 2024
EPS came in at $0.02 falling short of the estimated $0.06 by -66.67%, while revenue for the quarter reached $792.50m , beating expectations by +2.94%.
Earnings released on 27 Feb 2024
EPS came in at $0.64 surpassing the estimated $0.20 by +220.00%, while revenue for the quarter reached $858.23m , beating expectations by +3.87%.
Earnings released on 7 Nov 2023
EPS came in at $0.19 matching the estimated $0.19, while revenue for the quarter reached $804.03m , beating expectations by +0.93%.
Earnings released on 8 Aug 2023
EPS came in at $0.16 surpassing the estimated $0.11 by +45.45%, while revenue for the quarter reached $793.29m , beating expectations by +3.67%.
Earnings released on 9 May 2023
EPS came in at $0.01 falling short of the estimated $0.08 by -87.50%, while revenue for the quarter reached $744.63m , missing expectations by -1.56%.
Earnings released on 27 Feb 2023
EPS came in at $0.01 falling short of the estimated $0.31 by -96.77%, while revenue for the quarter reached $780.28m , missing expectations by -1.00%.
Earnings released on 8 Nov 2022
EPS came in at $0.11 falling short of the estimated $0.31 by -64.52%, while revenue for the quarter reached $557.65m , missing expectations by -24.43%.
Earnings released on 9 Aug 2022
EPS came in at $0.18 falling short of the estimated $0.28 by -35.71%, while revenue for the quarter reached $727.61m , beating expectations by +0.47%.
Earnings released on 10 May 2022
EPS came in at -$0.02 falling short of the estimated $0.21 by -109.52%, while revenue for the quarter reached $706.20m , beating expectations by +8.41%.
Earnings released on 24 Feb 2022
EPS came in at $0.17 falling short of the estimated $0.34 by -50.00%, while revenue for the quarter reached $702.11m , beating expectations by +1.75%.
Earnings released on 4 Nov 2021
EPS came in at $0.20 falling short of the estimated $0.34 by -41.18%, while revenue for the quarter reached $653.29m , beating expectations by +2.45%.
Earnings released on 5 Aug 2021
EPS came in at -$0.11 falling short of the estimated $0.29 by -137.93%, while revenue for the quarter reached $617.02m , meeting expectations.
AHCO Stock Performance
Access detailed AHCO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
